No Data
No Data
Express News | Corvus Pharmaceuticals Announces Publication In Science Signaling Demonstrating ITK Inhibition By Soquelitinib Induces Anti-Inflammatory Treg Cells; Study Highlights Potential For Treating Inflammatory Autoimmune And Allergic Diseases
Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) Stock Price Dropped 12% Last Week; Retail Investors Would Not Be Happy
Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference
13 Penny Stocks With Insider Buying in 2024
Insider Spends US$1m Buying More Shares In Corvus Pharmaceuticals
Express News | Steven Cohen Reports 9.9% Passive Stake in Corvus Pharmaceuticals Inc as of May 2 - SEC Filing